| Dr Donald E Kring Jr, DO | |
|
4100 Park Forest Dr, Suite 210, Traverse City, MI 49684-7331 | |
| (231) 935-5770 | |
| (231) 935-5878 |
| Full Name | Dr Donald E Kring Jr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 4100 Park Forest Dr, Traverse City, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285628016 | NPI | - | NPPES |
| CG1308 | Other | MI | RR - TSC |
| 2905551 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 5101008365 (Michigan) | Primary |
| Entity Name | The Pagosa Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255857660 PECOS PAC ID: 8729342936 Enrollment ID: O20180515001936 |
News Archive
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.
Smoking has long been the biggest cause of cancer in the United States, but obesity, now the second leading cause, has been gaining ground.
› Verified 9 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20191101001862 |
News Archive
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.
Smoking has long been the biggest cause of cancer in the United States, but obesity, now the second leading cause, has been gaining ground.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald E Kring Jr, DO 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684-7331 Ph: (231) 935-5770 | Dr Donald E Kring Jr, DO 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684-7331 Ph: (231) 935-5770 |
News Archive
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Chronix Biomedical today reported that it has significantly expanded and accelerated its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.
Smoking has long been the biggest cause of cancer in the United States, but obesity, now the second leading cause, has been gaining ground.
› Verified 9 days ago
Brian M Kiessling, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 | |
Kamala Wright, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 | |
Raymond J Omerza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 | |
Charles Kerndt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 | |
David S Feenstra, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 | |
Edward C Vomastek, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 210, Traverse City, MI 49684 Phone: 231-935-5770 Fax: 231-935-0747 |